These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 11525080

  • 1. Clinical management of neuroleptic malignant syndrome.
    Susman VL.
    Psychiatr Q; 2001; 72(4):325-36. PubMed ID: 11525080
    [Abstract] [Full Text] [Related]

  • 2. Therapy of neuroleptic malignant syndrome.
    Lazarus A.
    Psychiatr Dev; 1986; 4(1):19-30. PubMed ID: 3703852
    [Abstract] [Full Text] [Related]

  • 3. [Neuroleptic malignant syndrome].
    Reingardiene D.
    Medicina (Kaunas); 2002; 38(1):1-5. PubMed ID: 12474710
    [Abstract] [Full Text] [Related]

  • 4. Diagnosis and treatment of neuroleptic malignant syndrome.
    Guerrero RM, Shifrar KA.
    Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
    [Abstract] [Full Text] [Related]

  • 5. Management of neuroleptic malignant syndrome--a series of eight cases.
    Kurien T, Rajeev KK, Abraham OC, Archana S, Cherian AM.
    J Assoc Physicians India; 1993 Feb; 41(2):91-3. PubMed ID: 8101521
    [Abstract] [Full Text] [Related]

  • 6. Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome.
    Patel AL, Shaikh WA, Khobragade AK, Soni HG, Joshi AS, Sahastrabuddhe GS.
    J Assoc Physicians India; 2008 Jan; 56():49-50. PubMed ID: 18472502
    [Abstract] [Full Text] [Related]

  • 7. Neuroleptic malignant syndrome responsive to carbidopa/levodopa: support for a dopaminergic pathogenesis.
    Harris M, Nora L, Tanner CM.
    Clin Neuropharmacol; 1987 Apr; 10(2):186-9. PubMed ID: 3503673
    [Abstract] [Full Text] [Related]

  • 8. The neuroleptic malignant syndrome: occurrence in a 15-year-old boy and recovery with bromocriptine therapy.
    Tenenbein M.
    Pediatr Neurosci; 1987 Apr; 12(3):161-4. PubMed ID: 3870437
    [Abstract] [Full Text] [Related]

  • 9. Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy.
    Hashim H, Zeb-un-Nisa, Alrukn SA, Al Madani AA.
    J Pak Med Assoc; 2014 Apr; 64(4):471-3. PubMed ID: 24864649
    [Abstract] [Full Text] [Related]

  • 10. [Neuroleptic malignant syndrome].
    Murak E.
    Psychiatr Pol; 1995 Apr; 29(3):349-58. PubMed ID: 7652088
    [Abstract] [Full Text] [Related]

  • 11. Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause.
    Figà-Talamanca L, Gualandi C, Di Meo L, Di Battista G, Neri G, Lo Russo F.
    Neurology; 1985 Feb; 35(2):258-61. PubMed ID: 3969217
    [Abstract] [Full Text] [Related]

  • 12. Neuroleptic malignant syndrome in a patient on long-term olanzapine treatment at a stable dose: Successful treatment with dantrolene.
    Kouparanis A, Bozikas A, Spilioti M, Tziomalos K.
    Brain Inj; 2015 Feb; 29(5):658-60. PubMed ID: 25625410
    [Abstract] [Full Text] [Related]

  • 13. Neuroleptic malignant syndrome: a dangerous complication of neuroleptic therapy.
    Byrd C.
    J Neurosci Nurs; 1993 Feb; 25(1):62-5. PubMed ID: 8445278
    [Abstract] [Full Text] [Related]

  • 14. Suspected neuroleptic malignant syndrome in a patient receiving clozapine.
    Ganelin L, Lichtenberg PS, Marcus EL, Munter RG.
    Ann Pharmacother; 1996 Mar; 30(3):248-50. PubMed ID: 8833560
    [Abstract] [Full Text] [Related]

  • 15. A Severe Neuroleptic Malignant Syndrome Treated with Daily Electroconvulsive Therapy: A Case Report.
    Aki ÖE, Gürcan A, Gürel ŞC, Yazici MK.
    Turk Psikiyatri Derg; 2022 Mar; 33(2):139-142. PubMed ID: 35730514
    [Abstract] [Full Text] [Related]

  • 16. The neuroleptic malignant syndrome: agent and host interaction.
    Shalev A, Munitz H.
    Acta Psychiatr Scand; 1986 Apr; 73(4):337-47. PubMed ID: 2873715
    [Abstract] [Full Text] [Related]

  • 17. Neuroleptic malignant syndrome: further lessons from a case report.
    Casamassima F, Lattanzi L, Perlis RH, Litta A, Fui E, Bonuccelli U, Fricchione G, Cassano GB.
    Psychosomatics; 2010 Apr; 51(4):349-54. PubMed ID: 20587766
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neuroleptic malignant syndrome: guidelines for treatment and reinstitution of neuroleptics.
    Olmsted TR.
    South Med J; 1988 Jul; 81(7):888-91. PubMed ID: 2899358
    [Abstract] [Full Text] [Related]

  • 20. The neuroleptic malignant syndrome-a systematic case series analysis focusing on therapy regimes and outcome.
    Kuhlwilm L, Schönfeldt-Lecuona C, Gahr M, Connemann BJ, Keller F, Sartorius A.
    Acta Psychiatr Scand; 2020 Sep; 142(3):233-241. PubMed ID: 32659853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.